ThDerm
ActiveSummary
ThDerm has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €32,589 and a net result of €71,767. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 17% of 20,604 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2022 to 2025net €71,767 ▲5%
Operating result €91,767, net result €71,767, both a record.
15-05
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Equity above €100,000equity €131,822 ▲105%
A profit in every financial year since 2022 builds equity to €131,822.
07-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
06-03
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
Gazette deed
Registered office
Registered-office move · Director in office3 facts ▸
- General meeting, 26-01-2024
- Registered-office move, Quai sur Meuse,13 à 4000 Liège
- Director in office, DAMSIN Thomas (director)
2023
30-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.